(Q40624132)

22 September 2017

title

Enhanced expression of lymphotactin by CD8+ T cells is selectively induced by enhancer agonist peptides of tumor-associated antigens (English)

1 reference

22 September 2017

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

24 March 2024

5

Jeffrey Schlom

1 reference

22 September 2017

Claudia Palena

1

1 reference

22 September 2017

Philip Arlen

2

1 reference

22 September 2017

Hasan Zeytin

3

1 reference

22 September 2017

Kwong-Yok Tsang

6

1 reference

22 September 2017

John W. Greiner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14572791

24 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14572791

24 March 2024

publication date

1 November 2003

1 reference

22 September 2017

21 November 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14572791

full work available at URL

24 March 2024

https://api.elsevier.com/content/article/PII:S104346660300276X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

https://api.elsevier.com/content/article/PII:S104346660300276X?httpAccept=text/plain

24 March 2024

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

24 March 2024

1 reference

22 September 2017

volume

24

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

128-142

1 reference

Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen

22 September 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide

24 March 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

24 March 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen

24 March 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

24 March 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy

24 March 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists

24 March 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

24 March 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells

24 March 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen

24 March 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Altered peptide ligands induce quantitatively but not qualitatively different intracellular signals in primary thymocytes

24 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Cloning of ATAC, an activation-induced, chemokine-related molecule exclusively expressed in CD8+ T lymphocytes

24 March 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Staphylococcal superantigens induce lymphotactin production by human CD4+ and CD8+ T cells

24 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Neutrophils and B cells express XCR1 receptor and chemotactically respond to lymphotactin

24 March 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Role of C chemokine lymphotactin in mediating recruitment of antigen-specific CD62L(lo) cells in vitro and in vivo

24 March 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Role of gamma interferon in chemokine expression in the ileum of mice and in a murine intestinal epithelial cell line after Cryptosporidium parvum infection

24 March 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Detection of an up-regulation of a group of chemokine genes in murine cardiac allograft in the absence of interferon-gamma by means of DNA microarray

24 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Patterns of chemokine expression in models of Schistosoma mansoni inflammation and infection reveal relationships between type 1 and type 2 responses and chemokines in vivo.

24 March 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines

24 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Activation changes the spectrum but not the diversity of genes expressed by T cells.

24 March 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Probing lymphocyte biology by genomic-scale gene expression analysis.

24 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Gene regulation mediated by calcium signals in T lymphocytes

24 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Signatures of the immune response

24 March 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine

24 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses

24 March 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule

24 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Generation of Human Cytotoxic T Cells Specific for Human Carcinoembryonic Antigen Epitopes From Patients Immunized With Recombinant Vaccinia-CEA Vaccine

24 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen

24 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CYTO.2003.07.004

24 March 2024

Identifiers

1 reference

22 September 2017

1 reference